Lv1
40 积分 2024-04-13 加入
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
3个月前
已完结
“Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?”
3个月前
已关闭
Neurotoxicity and ototoxicity of cisplatin plus paclitaxel in comparison to cisplatin plus cyclophosphamide in patients with epithelial ovarian cancer
3个月前
已完结
Pancreatic cancer organoids recapitulate chemotherapy response and identify a potent cytotoxic T cell population
3个月前
已完结
Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor–Positive Breast Cancer
7个月前
已完结
Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses
9个月前
已完结
Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature
1年前
已关闭
Anthracyclines in basal breast cancer: The NCIC-CTG trial MA5 comparing adjuvant CMF to CEF
1年前
已关闭
皖公网安备34019202002308
